The GLP-1 wave is upon us: 13% of Canadian households have at least one member on GLP-1s—and 18% more are open to using a GLP-1 medication in the future. 

As these medications reshape Canadian consumer behaviour, brands and retailers must rethink what it means to connect and win with their consumers. Join Numerator’s Brian Ettkin, Head of Strategy and Solutions, Canada, on Tuesday, November 18th, 2025 at 11 AM ET for a forty-five minute data-driven look at how GLP-1 adoption influences consumer behaviour. 

The session will introduce Numerator’s new GLP-1 People Groups and custom analytics capabilities to help brands and retailers uncover actionable insights in this fast-evolving market.

We’ll cover:

• How the GLP-1 landscape is growing and changing in Canada
• Key lessons from the U.S. experience and academic research, featuring an exclusive conversation with Numerator Chief Economist, Dr. Leo Feler, whose research with Cornell University on the impacts of GLP-1 drugs on grocery shopping is guiding the understanding of CPG executives, financial institutions, researchers, and leading publications
• A conversation with Numerator Canada consultants about our initial findings from the Canadian data, including who new Canadian GLP-1 consumers are, what sets them apart, and how their habits are evolving
• How Numerator can help Canadian brands and retailers identify risks, opportunities, and behavioural trends

Whether you’re in CPG, retail, or foodservice, this session will equip you with actionable insights to navigate Canada’s changing consumer landscape.